Immunocore Signals Entry into Type 1 Diabetes
At the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on 14th January 2026, Immunocore outlined 2026 strategic priorities that extend its ImmTAX TCR-bispecific platform beyond oncology and infectious…